These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 11837141)
1. Is drug advertising informing the consumer? Hanlon PM Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141 [No Abstract] [Full Text] [Related]
2. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
3. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Rosenthal M J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239 [No Abstract] [Full Text] [Related]
4. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Morgan S; Mintzes B; Barer M J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759 [TBL] [Abstract][Full Text] [Related]
5. A consumer-empowered response to direct-to-consumer advertising of prescription drugs. Kemper DW; Mettler M Manag Care Q; 2002; 10(2):52-4. PubMed ID: 12148483 [TBL] [Abstract][Full Text] [Related]
7. When ads trump evidence: is direct-to-consumer advertising leading practice? Nelson R Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720 [No Abstract] [Full Text] [Related]
11. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny. Strawn MN J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255 [No Abstract] [Full Text] [Related]
13. Stoning a dead bird: advertising limits on approved new drugs. Strobos J Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018 [No Abstract] [Full Text] [Related]
14. The creation of the medical consumer. Berg TL S D Med; 2008 Feb; 61(2):42. PubMed ID: 18432148 [No Abstract] [Full Text] [Related]
15. [Can we rely on drug information?]. Myhr K Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198 [No Abstract] [Full Text] [Related]
16. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
17. [Written drug advertisements]. Kormeset PO Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1946; author reply 1946-7. PubMed ID: 16915329 [No Abstract] [Full Text] [Related]
18. [Information from drug producers]. Oye I Tidsskr Nor Laegeforen; 1977 May; 97(13):654-6. PubMed ID: 867358 [No Abstract] [Full Text] [Related]
19. Direct-to-consumer advertising: is it too late to manage the risks? Kessler DA; Levy DA Ann Fam Med; 2007; 5(1):4-5. PubMed ID: 17261858 [No Abstract] [Full Text] [Related]
20. Inconsistency in DTCA practices by manufacturers: is it time to standardize print summaries? Sansgiry SS; Kawatkar AA Value Health; 2004; 7(2):216-7. PubMed ID: 15164811 [No Abstract] [Full Text] [Related] [Next] [New Search]